NF-κB and the Transcriptional Control of Inflammation

International Review of Cell and Molecular Biology
Jennifer P Mitchell, Ruaidhrí J Carmody

Abstract

The NF-κB transcription factor was discovered 30 years ago and has since emerged as the master regulator of inflammation and immune homeostasis. It achieves this status by means of the large number of important pro- and antiinflammatory factors under its transcriptional control. NF-κB has a central role in inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and autoimmunity, as well as diseases comprising a significant inflammatory component such as cancer and atherosclerosis. Here, we provide an overview of the studies that form the basis of our understanding of the role of NF-κB subunits and their regulators in controlling inflammation. We also describe the emerging importance of posttranslational modifications of NF-κB in the regulation of inflammation, and highlight the future challenges faced by researchers who aim to target NF-κB transcriptional activity for therapeutic benefit in treating chronic inflammatory diseases.

Citations

Nov 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Patricia E CollinsRuaidhrí J Carmody
Feb 23, 2020·Journal of Receptor and Signal Transduction Research·Fang WangJingyao Zhang
Apr 24, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gang OuyangWuhan Xiao
Jun 27, 2020·The Journal of Biological Chemistry·Izaskun MitxitorenaRuaidhrí J Carmody
Apr 24, 2020·Cellular and Molecular Life Sciences : CMLS·Giovanna CarràAlessandro Morotti
Jun 23, 2020·Mediators of Inflammation·Hui SunJia-Lin Gao
Jun 18, 2020·World Journal of Clinical Cases·Ze-Yu WuBing Chang
May 2, 2019·Frontiers in Immunology·Ning SongLinlin Guo
Apr 30, 2020·Nature Reviews. Immunology·Giulia PetroniLorenzo Galluzzi
Aug 15, 2020·Frontiers in Pharmacology·Liliya N KirpotinaMark T Quinn
Oct 28, 2019·Oncoimmunology·Jenny SprootenAbhishek D Garg
Dec 15, 2019·Pathogens·Stefania FochiMaria Grazia Romanelli
Jul 2, 2020·Drug Design, Development and Therapy·Xin WangHequn Zou
Feb 25, 2020·BioMed Research International·Fang RenHong Sang
May 11, 2019·Genes·Esther Fuente-MartínBenoit R Gauthier
May 31, 2019·Cellular & Molecular Immunology·Tristan J de JesúsParameswaran Ramakrishnan
Oct 31, 2020·Frontiers in Pharmacology·Yujun TangYun Zhang
Nov 17, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Xu LanFengqin Xu
Feb 4, 2021·Journal of Cellular and Molecular Medicine·Jifei MiaoHui Li
Nov 17, 2020·Disease Markers·Xin HeNing Gu
Feb 13, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lili YangFengxiang Wei
Nov 17, 2020·Frontiers in Cell and Developmental Biology·Yayun Xu, Feihu Chen
Feb 21, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Dongsheng WangJianru Xiao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here